SINOPSIS DEL LIBRO

The pharmaceutical sector operates at a complex crossroads of public and private interests where innovation protected by patents and driven by high investment in research and development often clashes with the universal need for access to safe and affordable treatments Characterized as a differentiated oligopoly the market is subject to high regulation price controls and significant information asymmetry making it fertile ground for the prolifer...Seguir leyendo